| Dr Yvonne Claudia Naughton, MD | |
|
2101 Little Mountain Ln, Mount Vernon, WA 98274-8752 | |
| (360) 428-2622 | |
| Not Available |
| Full Name | Dr Yvonne Claudia Naughton |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 2101 Little Mountain Ln, Mount Vernon, Washington |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1669638128 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | R70643 (Arizona) | Secondary |
| 208000000X | Pediatrics | 60256682 (Washington) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Yvonne Claudia Naughton, MD 2101 Little Mountain Ln, Mount Vernon, WA 98274-8752 Ph: (360) 428-2622 | Dr Yvonne Claudia Naughton, MD 2101 Little Mountain Ln, Mount Vernon, WA 98274-8752 Ph: (360) 428-2622 |
News Archive
A major challenge in the field of neurodegeneration is the unclear understanding of neuronal dysfunction. Elucidation of these patho-mechanisms could result in the identification of novel therapeutic targets. In this article, Bell et al. present an exhaustive literature review highlighting the endoplasmic reticulum (ER) kinase PERK as a crucial contributor to systemic and neurodegenerative disorders.
Two independent, upcoming G&D papers lend new insight into the expression of microRNAs and their targets during vertebrate development.
Patients with epilepsy who underwent brain surgery soon after failing to respond to drug treatment, but who also continued to receive drug therapy, had a lower risk of seizures during the 2nd year of follow-up compared to patients who received drug treatment alone, according to a study in the March 7 issue of JAMA.
Home Diagnostics, Inc., a leading developer, manufacturer, and marketer of blood glucose monitoring systems, today announced the results of a TRUE2go™ clinical performance study published in the October 2009 issue of the journal Diabetes Technology & Therapeutics. The study, "Clinical Performance of the TRUE2go Blood Glucose System – A Novel Integrated System for Meter and Strips," demonstrated the accuracy and precision of the TRUE2go system and found that it was both easy and convenient to use by patients.
› Verified 8 days ago
Dr. Allan Michael Damian, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1415 E Kincaid St, Mount Vernon, WA 98274 Phone: 360-428-2550 Fax: 360-428-6402 | |
Erin E Charles, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1400 E Kincaid St, Mount Vernon, WA 98274 Phone: 360-428-2500 Fax: 360-428-6485 | |
Ariel Garcia, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 2101 Little Mountain Ln, Mount Vernon, WA 98274 Phone: 360-428-2622 | |
Mark R. Barr, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2101 Little Mountain Ln, Mount Vernon, WA 98274 Phone: 360-428-2622 Fax: 360-428-3941 | |
Barbara E Geraghty, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1400 E Kincaid St, Mount Vernon, WA 98274 Phone: 360-428-2500 Fax: 360-428-6485 | |
Cathy Kinyoun Webb, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1400 E Kincaid St, Mount Vernon, WA 98274 Phone: 360-428-2500 Fax: 360-428-6485 | |
Ms. Jill Kristine Hilden, DO Pediatrics Medicare: Medicare Enrolled Practice Location: 2320 Freeway Dr, Mount Vernon, WA 98273 Phone: 360-814-6870 Fax: 360-814-6922 |